发明名称 |
Use of L-2-oxothiazolidine-4-carboxylate alone or in combination with glutathione esters and/or amino acids in the treatment of reperfusion injury. |
摘要 |
<p>The use of L-2-oxothiazolidine-4-carboxylate for the preparation of a composition for treating and/or reducing ischemic reperfusion injury. To this end, in embodiment, the composition is used for treating and/or reducing reperfusion injury in a patient in danger of reperfusion injury. In an embodiment, the composition is used for limiting an expected ischemic reperfusion injury in a patient prior to an expected ischemic event. In a further embodiment of the present invention, the composition is used for limiting ischemic reperfusion injury in a patient after the onset of an ischemic event.</p> |
申请公布号 |
EP0501637(A2) |
申请公布日期 |
1992.09.02 |
申请号 |
EP19920301226 |
申请日期 |
1992.02.14 |
申请人 |
CLINTEC NUTRITION COMPANY |
发明人 |
GOLDBERG, DENNIS I.;MADSEN, DAVID C.;ROWE, BRUCE W. |
分类号 |
A61K31/095;A61K31/22;A61K31/425;A61K38/00;A61K45/00;A61P9/00;A61P9/10 |
主分类号 |
A61K31/095 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|